PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer

Alexandra Hockla, Erin Miller, Moh'd A. Salameh, John A. Copland, Derek C. Radisky, Evette S. Radisky

Research output: Contribution to journalArticle

29 Scopus citations

Fingerprint Dive into the research topics of 'PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences